Co-Regularized Deep Representations for Video Summarization

Compact keyframe-based video summaries are a popular way of generating viewership on video sharing platforms. Yet, creating relevant and compelling summaries for arbitrarily long videos with a small number of keyframes is a challenging task. We propose a comprehensive keyframe-based summarization framework combining deep convolutional neural networks and restricted Boltzmann machines. An original co-regularization scheme is used to discover meaningful subject-scene associations. The resulting multimodal representations are then used to select highly-relevant keyframes. A comprehensive user study is conducted comparing our proposed method to a variety of schemes, including the summarization currently in use by one of the most popular video sharing websites. The results show that our method consistently outperforms the baseline schemes for any given amount of keyframes both in terms of attractiveness and informativeness. The lead is even more significant for smaller summaries.Comment: Video summarization, deep convolutional neural networks, co-regularized restricted Boltzmann machine

Group Invariant Deep Representations for Image Instance Retrieval

Most image instance retrieval pipelines are based on comparison of vectors known as global image descriptors between a query image and the database images. Due to their success in large scale image classification, representations extracted from Convolutional Neural Networks (CNN) are quickly gaining ground on Fisher Vectors (FVs) as state-of-the-art global descriptors for image instance retrieval. While CNN-based descriptors are generally remarked for good retrieval performance at lower bitrates, they nevertheless present a number of drawbacks including the lack of robustness to common object transformations such as rotations compared with their interest point based FV counterparts. In this paper, we propose a method for computing invariant global descriptors from CNNs. Our method implements a recently proposed mathematical theory for invariance in a sensory cortex modeled as a feedforward neural network. The resulting global descriptors can be made invariant to multiple arbitrary transformation groups while retaining good discriminativeness. Based on a thorough empirical evaluation using several publicly available datasets, we show that our method is able to significantly and consistently improve retrieval results every time a new type of invariance is incorporated. We also show that our method which has few parameters is not prone to overfitting: improvements generalize well across datasets with different properties with regard to invariances. Finally, we show that our descriptors are able to compare favourably to other state-of-the-art compact descriptors in similar bitranges, exceeding the highest retrieval results reported in the literature on some datasets. A dedicated dimensionality reduction step --quantization or hashing-- may be able to further improve the competitiveness of the descriptors

Kernel methods for the incorporation of prior-knowledge into support vector machines

Ph.DDOCTOR OF PHILOSOPH

Time-efficient sparse analysis of histopathological Whole Slide Images

International audienceHistopathological examination is a powerful method for the prognosis of critical diseases. But, despite significant advances in high-speed and high-resolution scanning devices or in virtual exploration capabilities, the clinical analysis of Whole Slide Images (WSI) largely remains the work of human experts. We propose an innovative platform in which multi-scale computer vision algorithms perform fast analysis of a histopathological WSI. It relies on specific high and generic low resolution image analysis algorithms embedded in a multi-scale framework to rapidly identify the high power fields of interest used by the pathologist to assess a global grading. GPU technologies as well speed up the global time-efficiency of the system. In a sense, sparse coding and sampling is the keystone of our approach. In terms of validation, we are designing a computer-aided breast biopsy analysis application based on histopathology images and designed in collaboration with a pathology department. The current ground truth slides correspond to about 36,000 high magnification (40X) high power fields. The time processing to achieve automatic WSI analysis is on a par with the pathologist's performance (about ten minutes a WSI), which constitutes by itself a major contribution of the proposed methodology

Compression of Deep Neural Networks for Image Instance Retrieval

Image instance retrieval is the problem of retrieving images from a database which contain the same object. Convolutional Neural Network (CNN) based descriptors are becoming the dominant approach for generating global image descriptors for the instance retrieval problem. One major drawback of CNN-based global descriptors is that uncompressed deep neural network models require hundreds of megabytes of storage making them inconvenient to deploy in mobile applications or in custom hardware. In this work, we study the problem of neural network model compression focusing on the image instance retrieval task. We study quantization, coding, pruning and weight sharing techniques for reducing model size for the instance retrieval problem. We provide extensive experimental results on the trade-off between retrieval performance and model size for different types of networks on several data sets providing the most comprehensive study on this topic. We compress models to the order of a few MBs: Two orders of magnitude smaller than the uncompressed models while achieving negligible loss in retrieval performance1

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570